OXITOCINA PANPHARMA 5UI / ml perfusive solution concentrate medication leaflet

H01BB02 oxytocin • Systemic hormonal preparations, excluding sex hormones and insulins | Posterior pituitary lobe hormones | Oxytocin and analogues

Oxytocin is a hormone used in obstetrics to induce labor, stimulate uterine contractions, or control postpartum hemorrhage. It works by stimulating oxytocin receptors in the uterus, causing muscle contractions.

The medication is administered intravenously or intramuscularly, as directed by a doctor, usually in doses adjusted based on the patient's response. It is important for administration to be performed under strict medical supervision.

Patients should be aware of potential side effects, such as nausea, vomiting, or uterine hypertonia. It is important to inform the doctor of any unusual symptoms.

Common side effects include nausea, vomiting, and uterine hypertonia. In rare cases, severe reactions such as uterine rupture or allergic reactions may occur. Patients should be informed of these risks before use.

General data about OXITOCINA PANPHARMA 5UI / ml

Substance: oxytocin

Date of last drug list: 19-03-2019

Commercial code: W65329004

Concentration: 5UI / ml

Pharmaceutical form: perfusive solution concentrate

Quantity: 50

Product type: generic

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: ROTEXMEDICA GMBH - GERMANIA

Holder: PANPHARMA - FRANTA

Number: 10479/2018/04

Shelf life: 3 years-after packaging for sale;dupa diluare-it is used immediately

Concentrations available for oxytocin

16.7mcg/ml, 1UI/ml, 5UI/ml, 8.3mcg/ml

Other substances similar to oxytocin